TipRanks
Go Ultimate55% OFF

PharmaRoth Labs (ROTH) Financial Statements

PharmaRoth Labs Financial Overview

PharmaRoth Labs's market cap is currently $351. The company's EPS TTM is ―; its P/E ratio is -0.05; PharmaRoth Labs has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 17
Income Statement
Total Revenue$ 181.56K
Gross Profit$ 72.63K
Operating Income$ -91.58K
EBITDA$ -91.58K
Net Income$ -91.52K
Balance Sheet
Cash & Short-Term Investments$ 1.16K
Total Assets$ 304.05K
Total Debt$ 250.00K
Net Debt$ 248.84K
Total Liabilities$ 863.34K
Stockholders' Equity$ -549.48K
Cash Flow
Free Cash Flow$ -17.60K
Operating Cash Flow$ -17.60K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 18.00K

Currency in USD

PharmaRoth Labs Earnings and Revenue History

-120K0120K240K-52 %-51 %-50 %-49 %EarningsProfit Margin2017RevenueEarningsProfit Margin

PharmaRoth Labs Debt to Assets

0400K800K1.2M282 %283 %284 %285 %LiabilitiesDebt to Assets2017AssetsLiabilitiesDebt to Assets

PharmaRoth Labs Cash Flow

-20K-10K010K20K2017OperatingInvestingFinancing

PharmaRoth Labs Forecast EPS vs Actual EPS